DiscoverNEJM InterviewsNEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAV
NEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAV

NEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAV

Update: 2024-08-30
Share

Description

Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAV

NEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAV